We have previously demonstrated that heparins have a strong anti-hepcidin activity, both in vitro in hepatoma cells and in vivo in mice, and that they act by interfering with the BMP6/SMAD pathway [9, 27]. This evidence concerns the gene HAMP and hepatocellular carcinoma.